Latest On Vanda Pharmaceuticals Inc (VNDA):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-10 21:47 EST | News | Vanda to consider options after appeals court ruling on Hetlioz generics | N/A |  |
| 2023-05-04 05:11 EST | News | Vanda Pharmaceuticals reports Q1 results | N/A | |
| 2023-05-04 05:11 EST | News | Vanda Pharmaceuticals Inc. (VNDA) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-03-29 04:24 EST | News | Vanda wins FOIA litigation against FDA regarding Hetlioz for jet lag | N/A | |
| 2023-02-09 03:11 EST | News | Vanda Pharmaceuticals GAAP EPS of $0.12 beats by $0.04, revenue of $64.5M misses by $3.1M | N/A | |
| 2023-02-09 03:11 EST | News | Vanda Pharmaceuticals Inc. (VNDA) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-02-08 00:47 EST | News | Vanda Pharmaceuticals Q4 Earnings Preview | N/A | |
| 2022-12-28 19:15 EST | News | Federal appeals court lifts injunction barring generics of Vanda's Hetlioz | N/A | |
| 2022-12-18 14:07 EST | News | Vanda: Can The Company Turn Around? | N/A | |
| 2022-12-17 05:21 EST | News | Federal appeals court temporarily blocks generics of Vanda's Hetlioz by Teva, Apotex | N/A | |
| 2022-12-13 13:45 EST | News | Vanda Pharmaceuticals plunges after loss in Hetlioz patent case (update) | N/A | |
| 2022-12-02 12:55 EST | News | Vanda says performance anxiety drug lowered stress in Phase 2 enrollees | N/A | |
| 2022-11-16 02:48 EST | News | Vanda Pharmaceuticals (VNDA) Investor Presentation -Slideshow | N/A | |
| 2022-11-03 00:38 EST | News | Vanda Pharmaceuticals GAAP EPS of $0.06, revenue of $65.32M | N/A | |
| 2022-11-03 00:38 EST | News | Vanda Pharmaceuticals Inc. (VNDA) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-02 08:08 EST | News | Vanda Pharmaceuticals Q3 Earnings Preview | N/A | |
| 2022-10-25 17:58 EST | News | Vanda: VPO-227 Advancement Signals More Upsides | N/A | |
| 2022-10-22 05:22 EST | News | Vanda granted FDA’s Orphan Drug Designation for cholera therapy | N/A | |
| 2022-10-06 17:59 EST | News | Vanda Pharmaceuticals: What The Recent Partnership Entails | N/A | |
| 2022-09-30 08:29 EST | News | Vanda Pharma, OliPass collaborate to develop oligonucleotide-based therapeutics | N/A | |
| 2022-08-04 03:13 EST | News | Vanda Pharmaceuticals GAAP EPS of $0.05, revenue of $64.39M | N/A | |
| 2022-08-04 03:13 EST | News | Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-02 22:21 EST | News | Vanda Pharmaceuticals Q2 Earnings Preview | N/A | |
| 2022-05-17 19:04 EST | News | Vanda Pharmaceuticals: Strong Pipeline Developments To Power Long-Term Upside | N/A | |
| 2022-05-06 09:55 EST | News | Vanda Pharmaceuticals GAAP EPS of -$0.11 misses by $0.10, revenue of $60.19M beats by $2.19M | N/A | |
| 2022-05-06 09:55 EST | News | Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael H. Polymeropoulos on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-04-12 03:23 EST | News | Vanda: A Dual Growth And Value Player | N/A | |
| 2022-02-24 03:34 EST | News | Vanda Pharmaceuticals GAAP EPS of $0.12, revenue of $68.01M | N/A | |
| 2022-02-24 03:33 EST | News | Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-02-23 07:34 EST | News | Vanda Pharmaceuticals Q4 2021 Earnings Preview | N/A | |
| 2022-02-04 11:42 EST | News | Vanda falls 21% as tradipitant fails in phase 3 study for gastroparesis | N/A | |
| 2022-01-14 15:07 EST | News | Vanda in pact with MSN to settle HETLIOZ patent lawsuit | N/A | |
| 2021-12-30 20:11 EST | News | Vanda: A Prudent Business With Upsides | N/A | |
| 2021-11-19 21:50 EST | News | Vanda Pharmaceuticals (VNDA) Investor Presentation - Slideshow | N/A | |
| 2021-11-03 21:02 EST | News | Vanda Pharmaceuticals EPS misses by $0.04, misses on revenue | N/A | |
| 2021-11-03 21:02 EST | News | Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-03 01:23 EST | News | Vanda Pharmaceuticals Q3 2021 Earnings Preview | N/A | |
| 2021-07-29 06:43 EST | News | Vanda Pharmaceuticals EPS beats by $0.03, misses on revenue | N/A | |
| 2021-07-29 06:42 EST | News | Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-05-06 01:12 EST | News | Vanda Pharmaceuticals EPS beats by $0.01 | N/A | |
| 2021-05-06 01:12 EST | News | Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-04-04 23:32 EST | News | Vectoring Back In On Vanda Pharmaceuticals | N/A | |
| 2021-02-16 04:48 EST | Analyst Rating | The Analyst Target Price has increased from $18 to $21. | Buy | |
| 2021-02-15 04:48 EST | Analyst Rating | The Analyst Target Price has increased from $16 to $18. | Neutral | |
| 2021-02-12 00:53 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-11 15:13 EST | News | Vanda Pharmaceuticals Inc. (VNDA) CEO Mihael Polymeropoulos on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-02-11 04:52 EST | Earnings Estimate | An EPS average of $0.68 is estimated for the 2022 year. | Buy | |
| 2021-02-11 04:52 EST | Earnings Estimate | An EPS average of $0.15 is estimated for the quarter ending on June 30, 2021. | N/A | |
| 2021-01-01 04:59 EST | Analyst Rating | The Analyst Target Price has decreased from $19 to $16. | Neutral | |
| 2020-12-04 04:57 EST | Analyst Rating | The Analyst Target Price has increased from $18.33 to $19. | Buy | |
About Vanda Pharmaceuticals Inc (VNDA):
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist, for the treatment of atopic dermatitis, gastroparesis, and motion sickness. The company's products under development also comprise VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist for the treatment of psychiatric disorders; and a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors for the treatment of dry eye and ocular inflammation, as well as BPO-27 for the treatment of secretory diarrhea disorders, including cholera. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
General
- Name Vanda Pharmaceuticals Inc
- Symbol VNDA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 292
- Fiscal Year EndDecember
- IPO Date2006-04-12
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.vandapharma.com
View More
Valuation
- Trailing PE 40.57
- Forward PE 30.3
- Price/Sales (Trailing 12 Mt.) 3.9
- Price/Book (Most Recent Quarter) 2.12
- Enterprise Value Revenue 2.45
- Enterprise Value EBITDA 20.18
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $0.51
- Next Year EPS Estimate $0.79
- Next Quarter EPS Estimate $0.16
- Profit Margin 9%
- Operating Margin 11%
- Return on Assets 3%
- Return on Equity 5%
- Revenue 248.17 million
- Earnings Per Share $0.42
- Revenue Per Share $4.56
- Gross Profit 224.8 million
- Quarterly Earnings Growth 11%
View More
Highlights
- Market Capitalization 935.2 million
- EBITDA 30.1 million
- PE Ratio 110.64
- PEG Ratio -2.42
- Analyst Target Price $21
- Book Value Per Share $8.26
View More
Share Statistics
- Shares Outstanding 54.88 million
- Shares Float 39.6 million
- % Held by Insiders 327%
- % Held by Institutions 101.49%
- Shares Short 5.14 million
- Shares Short Prior Month 5.68 million
- Short Ratio 7.15
- Short % of Float 12%
- Short % of Shares Outstanding 9%
View More
Technicals
- Beta 0.52
- 52 Week High $20.51
- 52 Week Low $7.86
- 50 Day Moving Average 17.23
- 200 Day Moving Average 13.23
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Vanda Pharmaceuticals Inc (VNDA) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Vanda Pharmaceuticals Inc (VNDA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-10 | $N/A | $0.15 | $0.14 | 10.13% |
| 2020-09-30 | 2020-10-28 | $60.31 million | $0.11 | $0.10 | 6.9% |
| 2020-06-30 | 2020-08-05 | $N/A | $0.16 | $0.06 | 189.33% |
| 2020-03-31 | 2020-05-06 | $N/A | $0.01 | $0.00 | 455.56% |
| 2019-12-31 | 2020-02-25 | $60.93 million | $0.08 | $0.11 | -29.27% |
| 2019-09-30 | 2019-11-06 | $59.49 million | $1.84 | $0.07 | 2430.95% |
| 2019-06-30 | 2019-07-31 | $59.06 million | $0.21 | $0.02 | 775% |
| 2019-03-31 | 2019-05-01 | $47.71 million | -$0.01 | $0.08 | -111.99% |
| 2018-12-31 | 2019-02-13 | $53.04 million | $0.19 | $0.01 | 1838.78% |
| 2018-09-30 | 2018-11-07 | $49.14 million | $0.13 | -$0.02 | 622.09% |
| 2018-06-30 | 2018-08-01 | $47.35 million | $0.09 | -$0.16 | 155.11% |
| 2018-03-31 | 2018-05-02 | $43.59 million | $0.06 | -$0.13 | 146.15% |
| 2017-12-31 | 2018-02-14 | $44.28 million | -$0.04 | -$0.12 | 65.96% |
| 2017-09-30 | 2017-11-07 | $41.34 million | -$0.10 | -$0.11 | 6.98% |
| 2017-06-30 | 2017-08-02 | $42.06 million | -$0.03 | -$0.28 | 89.29% |
| 2017-03-31 | 2017-05-02 | $37.42 million | -$0.17 | -$0.23 | 25.27% |
| 2016-12-31 | 2017-02-15 | $38.24 million | -$0.01 | -$0.07 | 85.71% |
| 2016-09-30 | 2016-11-02 | $38.48 million | -$0.01 | -$0.08 | 87.5% |
| 2016-06-30 | 2016-07-27 | $36.03 million | -$0.11 | -$0.23 | 51.11% |
| 2016-03-31 | 2016-05-04 | $33.26 million | -$0.29 | -$0.28 | -5.45% |
| 2015-12-31 | 2016-02-10 | $31.85 million | -$0.35 | -$0.27 | -29.63% |
| 2015-09-30 | 2015-11-03 | $28.34 million | -$0.22 | -$0.20 | -10% |
| 2015-06-30 | 2015-07-29 | $27.58 million | -$0.13 | -$0.28 | 53.57% |
| 2015-03-31 | 2015-05-06 | $22.15 million | -$0.24 | -$0.25 | 4% |
| 2014-12-31 | 2015-02-19 | $15.37 million | -$0.20 | -$0.20 | 0% |
| 2014-09-30 | 2014-10-27 | $14.78 million | -$0.04 | -$0.39 | 89.74% |
| 2014-06-30 | 2014-08-07 | $10.86 million | -$0.64 | -$0.73 | 12.33% |
| 2014-03-31 | 2014-05-08 | $9.14 million | -$0.49 | -$0.29 | -68.97% |
| 2013-12-31 | 2014-02-13 | $8.78 million | -$0.23 | -$0.20 | -15% |
| 2013-09-30 | 2013-11-07 | $8.71 million | -$0.17 | -$0.30 | 43.33% |
| 2013-06-30 | 2013-07-31 | $8.32 million | -$0.11 | -$0.22 | 50% |
| 2013-03-31 | 2013-05-09 | $8.07 million | -$0.15 | -$0.25 | 40% |
| 2012-12-31 | 2013-02-12 | $7.92 million | -$0.23 | -$0.22 | -4.55% |
| 2012-09-30 | 2012-11-07 | $8.29 million | -$0.19 | -$0.22 | 13.64% |
| 2012-06-30 | 2012-08-02 | $8.38 million | -$0.28 | -$0.27 | -3.7% |
| 2012-03-31 | 2012-05-08 | $8.14 million | -$0.28 | -$0.16 | -75% |
| 2011-12-31 | 2012-02-14 | $8.37 million | -$0.20 | -$0.19 | -5.26% |
| 2011-09-30 | 2011-11-04 | $7.97 million | -$0.11 | -$0.07 | -57.14% |
| 2011-06-30 | 2011-08-04 | $7.43 million | -$0.05 | -$0.05 | 0% |
| 2011-03-31 | 2011-05-05 | $7.5 million | $0.00 | ||
| 2010-12-31 | 2011-02-10 | $7.75 million | $0.08 | -$0.02 | 500% |
| 2010-09-30 | 2010-11-03 | $7.25 million | $0.11 | $0.03 | 266.67% |
| 2010-06-30 | 2010-08-05 | $8.29 million | $0.04 | $0.09 | -55.56% |
| 2010-03-31 | 2010-05-04 | $12.42 million | $0.02 | $0.09 | -77.78% |
| 2009-12-31 | 2010-02-16 | $4.55 million | -$0.34 | -$0.16 | -112.5% |
| 2009-09-30 | 2009-11-02 | $N/A | -$0.28 | -$0.30 | 6.67% |
| 2009-06-30 | 2009-08-10 | $N/A | -$0.46 | -$0.41 | -12.2% |
| 2009-03-31 | 2009-04-29 | $N/A | -$0.24 | -$0.22 | -9.09% |
| 2008-12-31 | 2009-02-11 | $N/A | -$0.28 | -$0.36 | 22.22% |
| 2008-09-30 | 2008-10-30 | $N/A | -$0.41 | -$0.40 | -2.5% |
| 2008-06-30 | 2008-08-05 | $N/A | -$0.51 | -$0.63 | 19.05% |
| 2008-03-31 | 2008-05-01 | $N/A | -$0.72 | -$0.83 | 13.25% |
| 2007-12-31 | 2008-02-14 | $N/A | -$0.78 | -$0.79 | 1.27% |
| 2007-09-30 | 2007-11-08 | $N/A | -$0.82 | -$0.97 | 15.46% |
| 2007-06-30 | 2007-08-02 | $N/A | -$0.60 | -$0.81 | 25.93% |
| 2007-03-31 | 2007-05-01 | $N/A | -$0.61 | -$0.56 | -8.93% |
| 2006-12-31 | 2007-02-07 | $N/A | -$0.54 | -$0.64 | 15.63% |
| 2006-09-30 | 2006-11-02 | $N/A | -$0.55 | -$0.95 | 42.11% |
| 2006-06-30 | 2006-08-03 | $N/A | -$1.11 | -$0.83 | -33.73% |
| 2006-03-31 | 2006-05-18 | $N/A | -$385.61 |
Vanda Pharmaceuticals Inc (VNDA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | 12.3 million | N/A | N/A | 13.07 million |
| Income Before Tax | N/A | 8.4 million | N/A | N/A | 5.81 million |
| Selling General Administrative | N/A | 34 million | N/A | N/A | 37.02 million |
| Gross Profit | N/A | 54.41 million | N/A | N/A | 54.71 million |
| Ebit | N/A | 8.11 million | N/A | N/A | 4.24 million |
| Operating Income | N/A | 7.74 million | N/A | N/A | 4.24 million |
| Income Tax Expense | 2.73 million | 2.45 million | 2.38 million | 755000 | 1.59 million |
| Total Revenue | N/A | 60.31 million | N/A | N/A | 60.93 million |
| Cost of Revenue | N/A | 5.9 million | N/A | N/A | 6.23 million |
| Total Other Income Expense Net | N/A | 659000 | N/A | N/A | 1.57 million |
| Net Income From Continuing Operations | N/A | 5.95 million | N/A | N/A | 4.22 million |
| Net Income Applicable to Common Shares | 8.19 million | 5.95 million | 8.71 million | 486000 | 4.22 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | 525000 | 2.68 million | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | -47.85 million | 2.73 million | N/A | N/A | N/A |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Operating Activities | 2.95 million | 3.16 million | N/A | N/A | N/A |
| Change in Cash | N/A | N/A | N/A | N/A | N/A |
| Total Cash from Operating Activities | 9.37 million | 24.01 million | N/A | N/A | N/A |
| Depreciation | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Net Income | 5.82 million | 4.23 million | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | 75.33 million | N/A | N/A | 72.8 million |
| Total Stockholder Equity | N/A | 440.57 million | N/A | N/A | 410.95 million |
| Other Current Liabilities | 34.43 million | 32.27 million | N/A | N/A | 31.92 million |
| Total Assets | N/A | 515.91 million | N/A | N/A | 483.75 million |
| Common Stock | 55000 | 55000 | 55000 | 54000 | 54000 |
| Other Current Assets | N/A | 57000 | N/A | N/A | N/A |
| Retained Earnings | -197.33 million | -205.52 million | -211.47 million | -220.18 million | -220.67 million |
| Other Liabilities | 2.76 million | 2.42 million | 1.74 million | 778000 | 843000 |
| Other Assets | 88.16 million | 90.22 million | 89.13 million | 90.36 million | 91.53 million |
| Cash | N/A | 56.97 million | N/A | N/A | 45.07 million |
| Total Current Liabilities | 65.94 million | 61.36 million | N/A | N/A | 59.51 million |
| Other Stockholder Equity | 239000 | 379000 | 596000 | 781000 | 249000 |
| Property, Plant & Equipment | 14.6 million | 14.23 million | 14.35 million | 14.75 million | 15.04 million |
| Total Current Assets | 409.15 million | 389.53 million | N/A | N/A | 354.14 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 431.71 million | 418.64 million | 409.29 million | 393.72 million | 387.91 million |
| Short Term Investments | N/A | 291.58 million | N/A | N/A | 267.06 million |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | 1.28 million | 1.32 million | N/A | N/A | 1.14 million |
| Accounts Payable | 31.51 million | 1.83 million | N/A | N/A | 27.59 million |
Vanda Pharmaceuticals Inc (VNDA) Chart:
Vanda Pharmaceuticals Inc (VNDA) News:
Below you will find a list of latest news for Vanda Pharmaceuticals Inc (VNDA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Vanda Pharmaceuticals Inc (VNDA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 1 | 4.01 | CALL | 0 | 0 | 1013.48 | TRUE | 0 | 0 |
| 2024-05-17 | 2 | 2.4 | CALL | 0 | 1 | 422.28 | TRUE | 0 | 0 |
| 2024-05-17 | 3 | 1.85 | CALL | 3 | 30 | 186.04 | TRUE | 1.85 | 0 |
| 2024-05-17 | 4 | 0.85 | CALL | 24 | 355 | 90.98 | TRUE | 0.85 | 0 |
| 2024-05-17 | 5 | 0.25 | CALL | 132 | 1425 | 88.48 | FALSE | 0 | 0 |
| 2024-05-17 | 6 | 0.1 | CALL | 4 | 259 | 111.8 | FALSE | 0.1 | 0 |
| 2024-05-17 | 7 | 0.05 | CALL | 0 | 252 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 8 | 0.05 | CALL | 0 | 344 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 9 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 11 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 3 | 0.05 | PUT | 0 | 30 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 4 | 0.1 | PUT | 8 | 657 | 103.25 | FALSE | 0.1 | 0 |
| 2024-05-17 | 5 | 0.5 | PUT | 4 | 1206 | 96.33 | TRUE | 0.5 | 0 |
| 2024-05-17 | 6 | 1.8 | PUT | 0 | 219 | 113.83 | TRUE | 0 | 0 |
| 2024-05-17 | 7 | 2.55 | PUT | 0 | 7 | 213.95 | TRUE | 0 | 0 |
| 2024-05-17 | 8 | 0 | PUT | 0 | 0 | 205.89 | TRUE | 0 | 0 |
| 2024-05-17 | 9 | 0 | PUT | 0 | 0 | 295.6 | TRUE | 0 | 0 |
| 2024-05-17 | 10 | 0 | PUT | 0 | 0 | 194.19 | TRUE | 0 | 0 |
| 2024-05-17 | 11 | 0 | PUT | 0 | 0 | 554.41 | TRUE | 0 | 0 |
| 2024-06-21 | 1 | 4.1 | CALL | 0 | 2 | 553.63 | TRUE | 0 | 0 |
| 2024-06-21 | 2 | 1.9 | CALL | 0 | 19 | 0 | TRUE | 0 | 0 |
| 2024-06-21 | 3 | 2.57 | CALL | 0 | 353 | 115.21 | TRUE | 0 | 0 |
| 2024-06-21 | 4 | 0.95 | CALL | 1 | 1753 | 68.39 | TRUE | -0.05 | -0.05 |
| 2024-06-21 | 5 | 0.45 | CALL | 0 | 1872 | 68.43 | FALSE | 0 | 0 |
| 2024-06-21 | 6 | 0.2 | CALL | 0 | 1721 | 74.64 | FALSE | 0 | 0 |
| 2024-06-21 | 7 | 0.05 | CALL | 0 | 1089 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 8 | 0.14 | CALL | 0 | 147 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 9 | 0.35 | CALL | 0 | 25 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 11 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2 | 0.09 | PUT | 0 | 290 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 3 | 0.05 | PUT | 0 | 360 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 4 | 0.15 | PUT | 20 | 963 | 68.21 | FALSE | -0.1 | -0.4 |
| 2024-06-21 | 5 | 0.65 | PUT | 0 | 318 | 76.06 | TRUE | 0 | 0 |
| 2024-06-21 | 6 | 0 | PUT | 0 | 0 | 123.01 | TRUE | 0 | 0 |
| 2024-06-21 | 7 | 2.25 | PUT | 0 | 0 | 141.86 | TRUE | 0 | 0 |
| 2024-06-21 | 8 | 0 | PUT | 0 | 0 | 88.23 | TRUE | 0 | 0 |
| 2024-06-21 | 9 | 0 | PUT | 0 | 0 | 224.71 | TRUE | 0 | 0 |
| 2024-06-21 | 10 | 0 | PUT | 0 | 0 | 137.15 | TRUE | 0 | 0 |
| 2024-06-21 | 11 | 0 | PUT | 0 | 0 | 129.3 | TRUE | 0 | 0 |
| 2024-09-20 | 1 | 4.3 | CALL | 0 | 11 | 244.09 | TRUE | 0 | 0 |
| 2024-09-20 | 2 | 2.2 | CALL | 0 | 5 | 109.13 | TRUE | 0 | 0 |
| 2024-09-20 | 3 | 2 | CALL | 6 | 209 | 81.42 | TRUE | 2 | 0 |
| 2024-09-20 | 4 | 1.1 | CALL | 0 | 271 | 80.63 | TRUE | 0 | 0 |
| 2024-09-20 | 5 | 0.8 | CALL | 4 | 393 | 72.5 | FALSE | 0.8 | 0 |
| 2024-09-20 | 6 | 0.45 | CALL | 2 | 181 | 68.67 | FALSE | 0 | 0 |
| 2024-09-20 | 7 | 0.15 | CALL | 0 | 260 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 8 | 0.2 | CALL | 0 | 257 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 9 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 10 | 0.51 | CALL | 0 | 7 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 11 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 2 | 0.09 | PUT | 0 | 28 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 3 | 0.2 | PUT | 0 | 540 | 0 | FALSE | 0 | 0 |
| 2024-09-20 | 4 | 0.45 | PUT | 1 | 214 | 75.29 | FALSE | 0 | 0 |
| 2024-09-20 | 5 | 0.95 | PUT | 0 | 197 | 71.46 | TRUE | 0 | 0 |
| 2024-09-20 | 6 | 1.5 | PUT | 0 | 6 | 72.77 | TRUE | 0 | 0 |
| 2024-09-20 | 7 | 0 | PUT | 0 | 0 | 120.4 | TRUE | 0 | 0 |
| 2024-09-20 | 8 | 0 | PUT | 0 | 0 | 83.48 | TRUE | 0 | 0 |
| 2024-09-20 | 9 | 0 | PUT | 0 | 0 | 101.11 | TRUE | 0 | 0 |
| 2024-09-20 | 10 | 0 | PUT | 0 | 0 | 155.72 | TRUE | 0 | 0 |
| 2024-09-20 | 11 | 0 | PUT | 0 | 0 | 120.61 | TRUE | 0 | 0 |
| 2024-12-20 | 1 | 4 | CALL | 0 | 1 | 125.55 | TRUE | 0 | 0 |
| 2024-12-20 | 2 | 0 | CALL | 0 | 0 | 108.12 | TRUE | 0 | 0 |
| 2024-12-20 | 3 | 2 | CALL | 0 | 200 | 69.61 | TRUE | 0 | 0 |
| 2024-12-20 | 4 | 0.2 | CALL | 1 | 1 | 168.39 | TRUE | 0.2 | 0 |
| 2024-12-20 | 5 | 0.8 | CALL | 0 | 23 | 68.3 | FALSE | 0 | 0 |
| 2024-12-20 | 6 | 0.45 | CALL | 150 | 40 | 52.22 | FALSE | 0.45 | 0 |
| 2024-12-20 | 7 | 0.3 | CALL | 0 | 5 | 60.89 | FALSE | 0 | 0 |
| 2024-12-20 | 8 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 9 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 10 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 11 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-12-20 | 3 | 0.3 | PUT | 0 | 3 | 89.95 | FALSE | 0 | 0 |
| 2024-12-20 | 4 | 0 | PUT | 0 | 0 | 72.47 | FALSE | 0 | 0 |
| 2024-12-20 | 5 | 0.85 | PUT | 0 | 5 | 69.63 | TRUE | 0 | 0 |
| 2024-12-20 | 6 | 0 | PUT | 0 | 0 | 66.3 | TRUE | 0 | 0 |
| 2024-12-20 | 7 | 0 | PUT | 0 | 0 | 55.56 | TRUE | 0 | 0 |
| 2024-12-20 | 8 | 0 | PUT | 0 | 0 | 104.84 | TRUE | 0 | 0 |
| 2024-12-20 | 9 | 0 | PUT | 0 | 0 | 68.44 | TRUE | 0 | 0 |
| 2024-12-20 | 10 | 0 | PUT | 0 | 0 | 129.73 | TRUE | 0 | 0 |
| 2024-12-20 | 11 | 0 | PUT | 0 | 0 | 104.12 | TRUE | 0 | 0 |
Latest VNDA Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 6 | $9.33 |
| Jun 13, 2022 7:59 PM EST | 31 | $9.33 |
| Jun 13, 2022 7:59 PM EST | 38 | $9.33 |
| Jun 13, 2022 7:59 PM EST | 67 | $9.33 |
| Jun 13, 2022 7:59 PM EST | 100 | $9.33 |
Vanda Pharmaceuticals Inc (VNDA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120036787/0001209191-20-036787-index.htm |
| 2018-10-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000021545718006128/0000215457-18-006128-index.htm |
| 2019-01-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000021545719002580/0000215457-19-002580-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000083423720002791/0000834237-20-002791-index.htm |
| 2018-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000089924318011505/0000899243-18-011505-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000089924318016767/0000899243-18-016767-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000089924318016770/0000899243-18-016770-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000089924318016771/0000899243-18-016771-index.htm |
| 2018-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000089924318016772/0000899243-18-016772-index.htm |
| 2018-08-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000089924318022306/0000899243-18-022306-index.htm |
| 2018-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000089924318022312/0000899243-18-022312-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000091957419001741/0000919574-19-001741-index.htm |
| 2019-06-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000091957419004281/0000919574-19-004281-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000091957420001427/0000919574-20-001427-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000093247119004675/0000932471-19-004675-index.htm |
| 2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000103738920000046/0001037389-20-000046-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000108514619000752/0001085146-19-000752-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000108514620000850/0001085146-20-000850-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000110465920018247/0001104659-20-018247-index.htm |
| 2018-04-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1347178/000119312518136602/0001193125-18-136602-index.htm |
| 2018-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312518148659/0001193125-18-148659-index.htm |
| 2018-05-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1347178/000119312518148848/0001193125-18-148848-index.htm |
| 2018-05-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312518172007/0001193125-18-172007-index.htm |
| 2018-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312518181813/0001193125-18-181813-index.htm |
| 2018-06-01 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1347178/000119312518181873/0001193125-18-181873-index.htm |
| 2018-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312518191618/0001193125-18-191618-index.htm |
| 2018-06-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1347178/000119312518191629/0001193125-18-191629-index.htm |
| 2018-08-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312518234959/0001193125-18-234959-index.htm |
| 2018-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312518248669/0001193125-18-248669-index.htm |
| 2018-10-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312518293314/0001193125-18-293314-index.htm |
| 2018-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312518320885/0001193125-18-320885-index.htm |
| 2018-12-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312518341161/0001193125-18-341161-index.htm |
| 2018-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312518346177/0001193125-18-346177-index.htm |
| 2019-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519028756/0001193125-19-028756-index.htm |
| 2019-02-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519037960/0001193125-19-037960-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000119312519040377/0001193125-19-040377-index.htm |
| 2019-03-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519059344/0001193125-19-059344-index.htm |
| 2019-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519117199/0001193125-19-117199-index.htm |
| 2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519127449/0001193125-19-127449-index.htm |
| 2019-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519132921/0001193125-19-132921-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519143034/0001193125-19-143034-index.htm |
| 2019-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519169261/0001193125-19-169261-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519172528/0001193125-19-172528-index.htm |
| 2019-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519194896/0001193125-19-194896-index.htm |
| 2019-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519198589/0001193125-19-198589-index.htm |
| 2019-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519208676/0001193125-19-208676-index.htm |
| 2019-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519224024/0001193125-19-224024-index.htm |
| 2019-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519276286/0001193125-19-276286-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312519285883/0001193125-19-285883-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520006403/0001193125-20-006403-index.htm |
| 2020-01-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520011029/0001193125-20-011029-index.htm |
| 2020-02-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520022109/0001193125-20-022109-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000119312520035671/0001193125-20-035671-index.htm |
| 2020-02-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520041266/0001193125-20-041266-index.htm |
| 2020-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520043567/0001193125-20-043567-index.htm |
| 2020-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520048323/0001193125-20-048323-index.htm |
| 2020-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520049300/0001193125-20-049300-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520060483/0001193125-20-060483-index.htm |
| 2020-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520073086/0001193125-20-073086-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520134914/0001193125-20-134914-index.htm |
| 2020-05-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520141074/0001193125-20-141074-index.htm |
| 2020-06-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520166634/0001193125-20-166634-index.htm |
| 2020-06-11 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1347178/000119312520166765/0001193125-20-166765-index.htm |
| 2020-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520202550/0001193125-20-202550-index.htm |
| 2020-08-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000119312520223727/0001193125-20-223727-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001979/0001209191-19-001979-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001986/0001209191-19-001986-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001994/0001209191-19-001994-index.htm |
| 2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119002004/0001209191-19-002004-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119014962/0001209191-19-014962-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119014970/0001209191-19-014970-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119014978/0001209191-19-014978-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119014980/0001209191-19-014980-index.htm |
| 2019-03-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119014984/0001209191-19-014984-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015731/0001209191-19-015731-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015737/0001209191-19-015737-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015746/0001209191-19-015746-index.htm |
| 2019-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015749/0001209191-19-015749-index.htm |
| 2019-04-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119025776/0001209191-19-025776-index.htm |
| 2019-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119025783/0001209191-19-025783-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/0001209191-19-031781-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119037409/0001209191-19-037409-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119037410/0001209191-19-037410-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119037411/0001209191-19-037411-index.htm |
| 2019-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119037413/0001209191-19-037413-index.htm |
| 2019-08-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119046166/0001209191-19-046166-index.htm |
| 2019-08-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119047005/0001209191-19-047005-index.htm |
| 2019-08-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119047008/0001209191-19-047008-index.htm |
| 2019-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119047009/0001209191-19-047009-index.htm |
| 2019-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119047610/0001209191-19-047610-index.htm |
| 2019-10-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119054299/0001209191-19-054299-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119054300/0001209191-19-054300-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919119060380/0001209191-19-060380-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120002027/0001209191-20-002027-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120002029/0001209191-20-002029-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120002031/0001209191-20-002031-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120002032/0001209191-20-002032-index.htm |
| 2020-02-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120010513/0001209191-20-010513-index.htm |
| 2020-02-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120010516/0001209191-20-010516-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120014124/0001209191-20-014124-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120014126/0001209191-20-014126-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120014127/0001209191-20-014127-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120014129/0001209191-20-014129-index.htm |
| 2020-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120014132/0001209191-20-014132-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016197/0001209191-20-016197-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016200/0001209191-20-016200-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016204/0001209191-20-016204-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016208/0001209191-20-016208-index.htm |
| 2020-03-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016210/0001209191-20-016210-index.htm |
| 2020-03-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120020912/0001209191-20-020912-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120032896/0001209191-20-032896-index.htm |
| 2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120033491/0001209191-20-033491-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120036780/0001209191-20-036780-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120036782/0001209191-20-036782-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120036783/0001209191-20-036783-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120036785/0001209191-20-036785-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120036787/0001209191-20-036787-index.htm |
| 2020-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120043998/0001209191-20-043998-index.htm |
| 2020-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120043999/0001209191-20-043999-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120046804/0001209191-20-046804-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120046965/0001209191-20-046965-index.htm |
| 2020-08-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1347178/000120919120047991/0001209191-20-047991-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000130692319000010/0001306923-19-000010-index.htm |
| 2019-02-19 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000130692319000011/0001306923-19-000011-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1347178/000130692320000012/0001306923-20-000012-index.htm |
| 2018-08-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1347178/000134717818000007/0001347178-18-000007-index.htm |
| 2018-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1347178/000134717818000010/0001347178-18-000010-index.htm |
| 2019-02-19 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1347178/000134717819000003/0001347178-19-000003-index.htm |
| 2019-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1347178/000134717819000007/0001347178-19-000007-index.htm |
| 2019-04-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1347178/000134717819000008/0001347178-19-000008-index.htm |
| 2019-05-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1347178/000134717819000011/0001347178-19-000011-index.htm |
| 2019-08-01 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1347178/000134717819000014/0001347178-19-000014-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1347178/000134717819000017/0001347178-19-000017-index.htm |
| 2020-02-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1347178/000134717820000003/0001347178-20-000003-index.htm |
| 2020-04-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1347178/000134717820000009/0001347178-20-000009-index.htm |
| 2020-04-22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1347178/000134717820000010/0001347178-20-000010-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1347178/000134717820000013/0001347178-20-000013-index.htm |
| 2020-05-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000134717820000018/0001347178-20-000018-index.htm |
| 2020-05-26 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1347178/000134717820000019/0001347178-20-000019-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000134717820000022/0001347178-20-000022-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1347178/000134717820000024/0001347178-20-000024-index.htm |
| 2020-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1347178/000134717820000027/0001347178-20-000027-index.htm |
| 2020-10-29 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1347178/000134717820000030/0001347178-20-000030-index.htm |
| 2020-04-24 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1347178/999999999720002129/9999999997-20-002129-index.htm |
Vanda Pharmaceuticals Inc (VNDA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vanda Pharmaceuticals Inc (VNDA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 327%Institutional Ownership: 10149%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-06-13 | MICHAEL F COLA | Director | Buy | 5,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000089924318016772/0000899243-18-016772-index.htm | ||
| 2018-06-13 | MILANO VINCENT | Director | Buy | 5,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000089924318016770/0000899243-18-016770-index.htm | ||
| 2020-06-11 | Phaedra Chrousos | Director | Buy | 5,000.00 | 10,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120036780/0001209191-20-036780-index.htm | ||
| 2019-01-03 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 4,447.00 | 26.04 | 115,804.33 | 1,163,636.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001979/0001209191-19-001979-index.htm |
| 2019-01-02 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 3,056.00 | 26.93 | 82,310.30 | 1,168,083.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001979/0001209191-19-001979-index.htm |
| 2019-01-02 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 7,733.00 | 26.32 | 203,548.03 | 1,171,139.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001979/0001209191-19-001979-index.htm |
| 2019-03-04 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 38,166.00 | 19.41 | 740,802.06 | 1,178,970.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015746/0001209191-19-015746-index.htm |
| 2019-05-17 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 77,225.00 | 15.56 | 1,201,690.50 | 1,199,118.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/0001209191-19-031781-index.htm |
| 2019-05-20 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 67,418.00 | 15.12 | 1,019,083.75 | 1,205,308.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/0001209191-19-031781-index.htm |
| 2019-05-21 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 72,872.00 | 15.34 | 1,117,951.21 | 1,211,455.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/0001209191-19-031781-index.htm |
| 2019-03-01 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 6,500.00 | 20.22 | 131,423.50 | 1,217,136.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015746/0001209191-19-015746-index.htm |
| 2019-02-27 | Mihael Hristos Polymeropoulos | President and CEO | Buy | 60,000.00 | 1,223,636.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119014978/0001209191-19-014978-index.htm | ||
| 2019-12-11 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 72,373.00 | 16.92 | 1,224,377.46 | 1,228,281.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119060380/0001209191-19-060380-index.htm |
| 2020-01-02 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 9,467.00 | 16.00 | 151,492.83 | 1,234,579.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120002031/0001209191-20-002031-index.htm |
| 2019-12-12 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 70,036.00 | 16.98 | 1,189,351.35 | 1,244,046.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119060380/0001209191-19-060380-index.htm |
| 2019-05-20 | Mihael Hristos Polymeropoulos | President and CEO | Buy | 73,608.00 | 12.55 | 923,780.40 | 1,272,726.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/0001209191-19-031781-index.htm |
| 2019-05-17 | Mihael Hristos Polymeropoulos | President and CEO | Buy | 97,373.00 | 12.55 | 1,222,031.15 | 1,276,343.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/0001209191-19-031781-index.htm |
| 2020-03-03 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 5,152.00 | 10.98 | 56,544.23 | 1,278,999.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016204/0001209191-20-016204-index.htm |
| 2020-03-02 | Mihael Hristos Polymeropoulos | President and CEO | Sell | 10,428.00 | 10.57 | 110,211.45 | 1,284,151.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016204/0001209191-20-016204-index.htm |
| 2019-05-21 | Mihael Hristos Polymeropoulos | President and CEO | Buy | 79,019.00 | 12.55 | 991,688.45 | 1,284,327.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119031781/0001209191-19-031781-index.htm |
| 2020-02-26 | Mihael Hristos Polymeropoulos | President and CEO | Buy | 60,000.00 | 1,294,579.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120014127/0001209191-20-014127-index.htm | ||
| 2019-12-11 | Mihael Hristos Polymeropoulos | President and CEO | Buy | 89,199.00 | 10.65 | 949,969.35 | 1,300,654.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119060380/0001209191-19-060380-index.htm |
| 2019-12-12 | Mihael Hristos Polymeropoulos | President and CEO | Buy | 85,801.00 | 10.65 | 913,780.65 | 1,314,082.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119060380/0001209191-19-060380-index.htm |
| 2019-01-03 | Gunther Birznieks | SVP, Business Development | Sell | 1,619.00 | 26.09 | 42,231.62 | 133,780.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001994/0001209191-19-001994-index.htm |
| 2019-01-02 | Gunther Birznieks | SVP, Business Development | Sell | 1,170.00 | 26.95 | 31,527.99 | 135,399.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001994/0001209191-19-001994-index.htm |
| 2019-01-02 | Gunther Birznieks | SVP, Business Development | Sell | 3,272.00 | 26.30 | 86,050.33 | 136,569.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001994/0001209191-19-001994-index.htm |
| 2019-01-02 | Gian Piero Reverberi | SVP & Chief Commercial Officer | Sell | 530.00 | 26.94 | 14,275.55 | 138,870.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119002004/0001209191-19-002004-index.htm |
| 2019-01-02 | Gian Piero Reverberi | SVP & Chief Commercial Officer | Sell | 600.00 | 26.28 | 15,766.80 | 139,400.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119002004/0001209191-19-002004-index.htm |
| 2020-01-02 | Gunther Birznieks | SVP, Business Development | Sell | 4,020.00 | 15.93 | 64,021.31 | 147,231.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120002027/0001209191-20-002027-index.htm |
| 2019-06-13 | MICHAEL F COLA | Director | Buy | 5,000.00 | 15,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119037410/0001209191-19-037410-index.htm | ||
| 2019-03-04 | Gunther Birznieks | SVP, Business Development | Sell | 8,788.00 | 19.89 | 174,766.96 | 151,251.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015731/0001209191-19-015731-index.htm |
| 2020-03-03 | Gunther Birznieks | SVP, Business Development | Sell | 5,535.00 | 10.66 | 58,984.28 | 159,473.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016197/0001209191-20-016197-index.htm |
| 2019-03-01 | Gunther Birznieks | SVP, Business Development | Sell | 3,741.00 | 20.14 | 75,325.04 | 160,039.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015731/0001209191-19-015731-index.htm |
| 2019-02-27 | Gunther Birznieks | SVP, Business Development | Buy | 30,000.00 | 163,780.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119014962/0001209191-19-014962-index.htm | ||
| 2020-03-02 | Gunther Birznieks | SVP, Business Development | Sell | 12,223.00 | 10.04 | 122,685.92 | 165,008.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016197/0001209191-20-016197-index.htm |
| 2020-03-02 | Gian Piero Reverberi | SVP & Chief Commercial Officer | Sell | 1,450.00 | 10.18 | 14,755.20 | 165,384.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016208/0001209191-20-016208-index.htm |
| 2020-01-02 | Gian Piero Reverberi | SVP & Chief Commercial Officer | Sell | 1,155.00 | 16.06 | 18,550.69 | 166,834.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120002032/0001209191-20-002032-index.htm |
| 2019-03-04 | Gian Piero Reverberi | SVP & Chief Commercial Officer | Sell | 443.00 | 19.92 | 8,822.79 | 167,989.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015749/0001209191-19-015749-index.htm |
| 2019-03-01 | Gian Piero Reverberi | SVP & Chief Commercial Officer | Sell | 438.00 | 20.17 | 8,832.27 | 168,432.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015749/0001209191-19-015749-index.htm |
| 2019-02-27 | Gian Piero Reverberi | SVP & Chief Commercial Officer | Buy | 30,000.00 | 168,870.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119014980/0001209191-19-014980-index.htm | ||
| 2020-02-26 | Gunther Birznieks | SVP, Business Development | Buy | 30,000.00 | 177,231.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120014124/0001209191-20-014124-index.htm | ||
| 2020-03-03 | James Patrick Kelly | EVP & Chief Financial Officer | Sell | 5,889.00 | 10.76 | 63,359.16 | 186,869.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016200/0001209191-20-016200-index.htm |
| 2020-03-02 | James Patrick Kelly | EVP & Chief Financial Officer | Sell | 12,968.00 | 10.19 | 132,086.86 | 192,758.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016200/0001209191-20-016200-index.htm |
| 2019-01-03 | James Patrick Kelly | EVP & Chief Financial Officer | Sell | 1,619.00 | 26.09 | 42,231.62 | 193,473.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001986/0001209191-19-001986-index.htm |
| 2019-01-02 | James Patrick Kelly | EVP & Chief Financial Officer | Sell | 1,129.00 | 26.94 | 30,414.13 | 195,092.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001986/0001209191-19-001986-index.htm |
| 2019-01-02 | James Patrick Kelly | EVP & Chief Financial Officer | Sell | 3,313.00 | 26.31 | 87,165.03 | 196,221.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119001986/0001209191-19-001986-index.htm |
| 2018-05-03 | Thomas Watkins | Director | Buy | 15,000.00 | 4.98 | 74,700.00 | 20,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000089924318011505/0000899243-18-011505-index.htm |
| 2020-01-02 | James Patrick Kelly | EVP & Chief Financial Officer | Sell | 4,020.00 | 15.94 | 64,086.04 | 205,726.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120002029/0001209191-20-002029-index.htm |
| 2019-03-04 | James Patrick Kelly | EVP & Chief Financial Officer | Sell | 8,751.00 | 19.88 | 173,961.13 | 209,746.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015737/0001209191-19-015737-index.htm |
| 2019-03-01 | James Patrick Kelly | EVP & Chief Financial Officer | Sell | 4,976.00 | 20.15 | 100,271.38 | 218,497.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119015737/0001209191-19-015737-index.htm |
| 2019-02-27 | James Patrick Kelly | EVP & Chief Financial Officer | Buy | 30,000.00 | 223,473.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119014970/0001209191-19-014970-index.htm | ||
| 2018-06-13 | Thomas Watkins | Director | Buy | 5,000.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000089924318016767/0000899243-18-016767-index.htm | ||
| 2019-08-19 | Joakim Wijkstrom | SVP, Chief Marketing Officer | Buy | 30,000.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119047009/0001209191-19-047009-index.htm | ||
| 2019-06-13 | Thomas Watkins | Director | Buy | 5,000.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119037413/0001209191-19-037413-index.htm | ||
| 2018-08-13 | Timothy Williams | SVP & General Counsel | Buy | 30,000.00 | 30,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000089924318022312/0000899243-18-022312-index.htm | ||
| 2018-06-13 | RICHARD W DUGAN | Director | Buy | 5,000.00 | 30,770.00 | https://www.sec.gov/Archives/edgar/data/1347178/000089924318016771/0000899243-18-016771-index.htm | ||
| 2020-05-29 | Thomas Watkins | Director | Sell | 9,677.00 | 11.50 | 111,285.50 | 35,323.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120033491/0001209191-20-033491-index.htm |
| 2019-06-13 | RICHARD W DUGAN | Director | Buy | 5,000.00 | 35,770.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119037411/0001209191-19-037411-index.htm | ||
| 2019-08-26 | RICHARD W DUGAN | Director | Sell | 15,000.00 | 14.85 | 222,750.00 | 35,770.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119047610/0001209191-19-047610-index.htm |
| 2020-06-11 | Thomas Watkins | Director | Buy | 5,000.00 | 40,323.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120036787/0001209191-20-036787-index.htm | ||
| 2020-05-28 | RICHARD W DUGAN | Director | Sell | 10,129.00 | 11.04 | 111,805.93 | 40,641.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120032896/0001209191-20-032896-index.htm |
| 2020-05-29 | Thomas Watkins | Director | Buy | 15,000.00 | 7.38 | 110,700.00 | 45,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120033491/0001209191-20-033491-index.htm |
| 2020-06-11 | RICHARD W DUGAN | Director | Buy | 5,000.00 | 45,641.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120036782/0001209191-20-036782-index.htm | ||
| 2020-06-11 | Anne Sempowski Ward | Director | Buy | 5,000.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120036785/0001209191-20-036785-index.htm | ||
| 2019-06-13 | Phaedra Chrousos | Director | Buy | 5,000.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119037409/0001209191-19-037409-index.htm | ||
| 2019-08-26 | RICHARD W DUGAN | Director | Buy | 15,000.00 | 14.78 | 221,700.00 | 50,770.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119047610/0001209191-19-047610-index.htm |
| 2020-05-28 | RICHARD W DUGAN | Director | Buy | 15,000.00 | 7.38 | 110,700.00 | 50,770.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120032896/0001209191-20-032896-index.htm |
| 2020-06-11 | Stephen Ray Mitchell | Director | Buy | 5,000.00 | 5,200.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120036783/0001209191-20-036783-index.htm | ||
| 2020-08-20 | Joakim Wijkstrom | SVP, Chief Marketing Officer | Sell | 3,710.00 | 11.08 | 41,109.03 | 56,290.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120047991/0001209191-20-047991-index.htm |
| 2019-08-14 | Timothy Williams | SVP & General Counsel | Sell | 2,575.00 | 14.69 | 37,829.33 | 57,425.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119046166/0001209191-19-046166-index.htm |
| 2020-02-26 | Joakim Wijkstrom | SVP, Chief Marketing Officer | Buy | 30,000.00 | 60,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120014129/0001209191-20-014129-index.htm | ||
| 2019-02-27 | Timothy Williams | SVP & General Counsel | Buy | 30,000.00 | 60,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919119014984/0001209191-19-014984-index.htm | ||
| 2020-08-12 | Aranthan II Jones | Chief Corp. Affairs Officer | Sell | 7,200.00 | 11.81 | 85,018.32 | 75,487.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120046804/0001209191-20-046804-index.htm |
| 2020-07-27 | Kevin Patrick Moran | SVP, CFO & Treasurer | Buy | 17,344.00 | 78,097.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120043999/0001209191-20-043999-index.htm | ||
| 2020-08-14 | Timothy Williams | SVP & General Counsel | Sell | 3,684.00 | 11.81 | 43,526.09 | 79,356.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120046965/0001209191-20-046965-index.htm |
| 2020-07-27 | Aranthan II Jones | Chief Corp. Affairs Officer | Sell | 7,313.00 | 10.62 | 77,631.15 | 82,687.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120043998/0001209191-20-043998-index.htm |
| 2020-03-03 | Timothy Williams | SVP & General Counsel | Sell | 1,237.00 | 10.51 | 13,003.84 | 83,040.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016210/0001209191-20-016210-index.htm |
| 2020-03-02 | Timothy Williams | SVP & General Counsel | Sell | 3,148.00 | 10.30 | 32,435.73 | 84,277.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120016210/0001209191-20-016210-index.htm |
| 2020-02-26 | Timothy Williams | SVP & General Counsel | Buy | 30,000.00 | 87,425.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120014132/0001209191-20-014132-index.htm | ||
| 2020-02-26 | Aranthan II Jones | Chief Corp. Affairs Officer | Buy | 30,000.00 | 90,000.00 | https://www.sec.gov/Archives/edgar/data/1347178/000120919120014126/0001209191-20-014126-index.htm |